N9879
NADase from porcine brain
≥0.007 unit/mg solid
Synonym(s):
DPN Nucleosidase, NAD+ glycohydrolase
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
| Pack Size | SKU | Availability | Price |
|---|
About This Item
CAS Number:
UNSPSC Code:
12352204
NACRES:
NA.54
MDL number:
Specific activity:
≥0.007 unit/mg solid
Pricing and availability is not currently available.
form
powder
Quality Level
specific activity
≥0.007 unit/mg solid
solubility
insoluble
storage temp.
−20°C
General description
NADase is a glycohydrolase that catalyzes ADP-ribose transfer. [1]
Application
NADase from porcine brain has been used in a study to investigate histidine and related compounds resulting from catalyzed ADP-riboslyation. It has also been used in a study to investigate the preparation of arylazide-substituted pyridine adenine dinucleotides for photoaffinity labeling.
Biochem/physiol Actions
Nicotinamide has been shown to inhibit NADase activity. [2]
Physical form
Acetone-dried powder
Other Notes
One unit will hydrolyze 1.0 μmole of β-NAD to nicotinamide and ADP-ribose per min at pH 7.3 at 37 °C.
1 of 1
This Item | |||
|---|---|---|---|
| specific activity ≥0.007 unit/mg solid | specific activity ≥400 units/mg protein (biuret) | specific activity ≥600 units/mg protein (biuret) | specific activity ≥200 units/mg protein |
| form powder | form ammonium sulfate suspension | form ammonium sulfate suspension | form ammonium sulfate suspension |
| solubility insoluble | solubility - | solubility - | solubility - |
| storage temp. −20°C | storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C |
| Quality Level 200 | Quality Level - | Quality Level 200 | Quality Level 200 |
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
QC Methods
D San Segundo et al.
Transplantation proceedings, 44(9), 2676-2678 (2012-11-14)
Posttransplant infection after lung transplantation is a common feature due to the immunodeficiency induced by the immunosuppressive load. To assess B-cell subsets in lung transplant recipients suffering at least one episode of infection within the first year posttransplantation. Twenty-eight lung
Drug-resistant virus has reduced ability to induce immune activation.
Rui Wang et al.
Journal of acquired immune deficiency syndromes (1999), 61(4), e60-e63 (2012-11-10)
Ding-bao Chen et al.
Zhonghua bing li xue za zhi = Chinese journal of pathology, 41(9), 607-612 (2012-11-20)
To study the clinical and histopathologic features, diagnosis, pathogenesis and therapy of post-transplant lymphoproliferative disorders (PTLD). The clinical and pathologic features of 15 cases of PTLD were retrospectively analyzed by light microscopy, immunohistochemistry and in-situ hybridization, according to the updated
Global Trade Item Number
| SKU | GTIN |
|---|---|
| N9879-5G | 04061832851082 |